: We investigated the neutrophil-to-lymphocyte ratio (NLR) as a predictor of thrombosis in polycythemia vera (PV). After a median follow-up of 2.51 years, of 1508 PV patients enrolled in the ECLAP study, 82 and 84 developed arterial and venous thrombosis, respectively. Absolute counts of total leukocytes, neutrophils, lymphocytes, platelets, and the NLR were tested by generalized additive models (GAM) to evaluate their trend in continuous scale of thrombotic risk. Only for venous thrombosis, we showed that baseline absolute neutrophil and lymphocyte counts were on average respectively higher (median: 6.8 × 109/L, p = 0.002) and lower (median: 1.4 × 109/L, p = 0.001), leading to increased NLR values (median: 5.1, p = 0.002). In multivariate analysis, the risk of venous thrombosis was independently associated with previous venous events (HR = 5.48, p ≤ 0.001) and NLR values ≥5 (HR = 2.13, p = 0.001). Moreover, the relative risk in both low- and high-standard risk groups was almost doubled in the presence of NLR ≥ 5. These findings were validated in two Italian independent external cohorts (Florence, n = 282 and Rome, n = 175) of contemporary PV patients. Our data support recent experimental work that venous thrombosis is controlled by innate immune cells and highlight that NLR is an inexpensive and easily accessible prognostic biomarker of venous thrombosis.

Neutrophil-to-lymphocyte ratio is a novel predictor of venous thrombosis in polycythemia vera / Carobbio, Alessandra; Vannucchi, Alessandro Maria; De Stefano, Valerio; Masciulli, Arianna; Guglielmelli, Paola; Loscocco, Giuseppe Gaetano; Ramundo, Francesco; Rossi, Elena; Kanthi, Yogendra; Tefferi, Ayalew; Barbui, Tiziano. - In: BLOOD CANCER JOURNAL. - ISSN 2044-5385. - 12:2(2022), pp. 28-28. [10.1038/s41408-022-00625-5]

Neutrophil-to-lymphocyte ratio is a novel predictor of venous thrombosis in polycythemia vera

Carobbio, Alessandra;
2022

Abstract

: We investigated the neutrophil-to-lymphocyte ratio (NLR) as a predictor of thrombosis in polycythemia vera (PV). After a median follow-up of 2.51 years, of 1508 PV patients enrolled in the ECLAP study, 82 and 84 developed arterial and venous thrombosis, respectively. Absolute counts of total leukocytes, neutrophils, lymphocytes, platelets, and the NLR were tested by generalized additive models (GAM) to evaluate their trend in continuous scale of thrombotic risk. Only for venous thrombosis, we showed that baseline absolute neutrophil and lymphocyte counts were on average respectively higher (median: 6.8 × 109/L, p = 0.002) and lower (median: 1.4 × 109/L, p = 0.001), leading to increased NLR values (median: 5.1, p = 0.002). In multivariate analysis, the risk of venous thrombosis was independently associated with previous venous events (HR = 5.48, p ≤ 0.001) and NLR values ≥5 (HR = 2.13, p = 0.001). Moreover, the relative risk in both low- and high-standard risk groups was almost doubled in the presence of NLR ≥ 5. These findings were validated in two Italian independent external cohorts (Florence, n = 282 and Rome, n = 175) of contemporary PV patients. Our data support recent experimental work that venous thrombosis is controlled by innate immune cells and highlight that NLR is an inexpensive and easily accessible prognostic biomarker of venous thrombosis.
2022
12
2
28
28
Neutrophil-to-lymphocyte ratio is a novel predictor of venous thrombosis in polycythemia vera / Carobbio, Alessandra; Vannucchi, Alessandro Maria; De Stefano, Valerio; Masciulli, Arianna; Guglielmelli, Paola; Loscocco, Giuseppe Gaetano; Ramundo, Francesco; Rossi, Elena; Kanthi, Yogendra; Tefferi, Ayalew; Barbui, Tiziano. - In: BLOOD CANCER JOURNAL. - ISSN 2044-5385. - 12:2(2022), pp. 28-28. [10.1038/s41408-022-00625-5]
Carobbio, Alessandra; Vannucchi, Alessandro Maria; De Stefano, Valerio; Masciulli, Arianna; Guglielmelli, Paola; Loscocco, Giuseppe Gaetano; Ramundo, Francesco; Rossi, Elena; Kanthi, Yogendra; Tefferi, Ayalew; Barbui, Tiziano
File in questo prodotto:
File Dimensione Formato  
2022_Blood Cancer J_Neutrophil-to-lymphocyte ratio is a novel predictor of venous thrombosis in polycythemia vera.pdf

Open access

Tipologia: Versione pubblicata dall'editore
Dimensione 1.06 MB
Formato Adobe PDF
1.06 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1332049
Citazioni
  • ???jsp.display-item.citation.pmc??? 15
  • Scopus 27
  • ???jsp.display-item.citation.isi??? 26
social impact